186 related articles for article (PubMed ID: 38066444)
21. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
22. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
23. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
24. Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
Correa RM; Baena A; Valls J; Colucci MC; Mendoza L; Rol M; Wiesner C; Ferrera A; Fellner MD; González JV; Basiletti JA; Mongelos P; Rodriguez de la Peña M; Saino A; Kasamatsu E; Velarde C; Macavilca N; Martinez S; Venegas G; Calderón A; Rodriguez G; Barrios H; Herrero R; Almonte M; Picconi MA;
PLoS One; 2022; 17(7):e0272205. PubMed ID: 35905130
[TBL] [Abstract][Full Text] [Related]
25. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
26. Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
Sideri M; Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT
Gynecol Oncol; 2011 Jun; 121(3):510-3. PubMed ID: 21396686
[TBL] [Abstract][Full Text] [Related]
27. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3).
González-Bosquet E; Esteva C; Muñoz-Almagro C; Ferrer P; Pérez M; Lailla JM
Gynecol Oncol; 2008 Oct; 111(1):9-12. PubMed ID: 18684497
[TBL] [Abstract][Full Text] [Related]
28. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
29. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study.
Bai A; Xue P; Li Q; Jiang Y; Qiao Y
Cancer Med; 2023 Jul; 12(13):14794-14805. PubMed ID: 37199394
[TBL] [Abstract][Full Text] [Related]
31. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
Zhang J; Cheng K; Wang Z
Arch Gynecol Obstet; 2020 Dec; 302(6):1329-1337. PubMed ID: 32914222
[TBL] [Abstract][Full Text] [Related]
33. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
Zhang L; Bi Q; Deng H; Xu J; Chen J; Zhang M; Mu X
BMC Infect Dis; 2017 Jan; 17(1):107. PubMed ID: 28143439
[TBL] [Abstract][Full Text] [Related]
35. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
Wang H; Cheng X; Ye J; Xu X; Hong Y; Sui L; You Z; Xie X
BMC Cancer; 2018 Apr; 18(1):487. PubMed ID: 29703167
[TBL] [Abstract][Full Text] [Related]
36. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
[TBL] [Abstract][Full Text] [Related]
37. Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.
Spinillo A; Gardella B; Roccio M; Alberizzi P; Cesari S; Patrizia M; Silini E
Cancer Causes Control; 2014 Dec; 25(12):1669-76. PubMed ID: 25296710
[TBL] [Abstract][Full Text] [Related]
38. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A
J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626
[TBL] [Abstract][Full Text] [Related]
39. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
[TBL] [Abstract][Full Text] [Related]
40. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]